Research ArticleResearchPatient Education

Self-acupressure improved a fatigue, sleep, and depression symptom cluster in one small trial

Supportive Care in Cancer (PubMed)Sep 17, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

In a three-group randomized trial of breast cancer survivors, seven weeks of true self-acupressure improved the combined fatigue, sleep-disturbance, and depression symptom score compared with sham self-acupressure and usual care through 19 weeks.

What NurseJet pulled from the source

The trial assigned 108 participants equally to true self-acupressure, sham self-acupressure, or usual care, and 93 completed it. The true-acupressure group had better cluster scores than both comparison groups at weeks 7 and 19; no adverse events were reported.

Why this matters for nurses

Fatigue, sleep disturbance, and depressive symptoms frequently overlap during breast cancer survivorship. The trial identifies a low-resource supportive option worth further study, while the small sample and mixed sham comparisons argue against overstating the effect.

Bedside takeaway

Treat self-acupressure as an adjunctive survivorship option and continue structured assessment of fatigue, sleep, and mood.

Key takeaways

Sleep-quality and depression scores were better with true self-acupressure than with both comparison groups at the end of treatment and follow-up.
Fatigue was lower than usual care at both time points, but the difference from sham acupressure was statistically significant only at follow-up.
Quality of life was better than usual care at both time points, while the difference from sham acupressure was not statistically significant immediately after treatment.

Practice implications

Assess fatigue, sleep, mood, and quality-of-life concerns together and escalate significant or worsening symptoms through the survivorship pathway. If self-acupressure is available within an approved supportive-care plan, present it as an adjunct rather than a replacement for evaluation or treatment.

Limitations & cautions

This was a small trial with 108 randomized participants and 93 completers. Some outcomes did not differ from sham treatment immediately after the intervention, clinical effect sizes were not reported in the abstract, and cost-effectiveness remains unknown.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Supportive Care in Cancer (PubMed)

Supportive Care in Cancer (PubMed). Effects of self-acupressure on the fatigue-sleep disturbance-depression symptom cluster in breast cancer survivors: a phase III randomised controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42749858/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Breast Cancer Research and Treatment (PubMed)Sep 22, 2026Systematic Review

A systematic review and meta-analysis found that ovarian function recovery after chemotherapy was limited among premenopausal women with breast cancer and increased over time, with older age and longer chemotherapy associated with lower recovery odds.

Oncology L&D / OBAI summaryReview source

Systematic ReviewResearchPatient EducationWorkflowAI summary · original source linked below

Across 34 studies including 10,216 women, pooled recovery probabilities were 30.4% at 12 months, 38.5% at 24 months, and 43.4% at 60 months. The pooled mean time to recovery was 12.3 months, and the wide confidence intervals show substantial uncertainty around longer-term estimates.

Key takeaways

Older age was associated with lower odds of ovarian function recovery, with a pooled odds ratio of 0.25.
Longer chemotherapy duration was also associated with lower recovery odds, with a pooled odds ratio of 0.68.
Pretreatment anti-Müllerian hormone appeared favorable in individual studies, but the pooled association was not statistically significant.

Why this matters on shift

Oncology nurses often identify fertility concerns, prepare patients for treatment effects, and coordinate referrals. The findings reinforce the importance of discussing reproductive risk and established fertility-preservation options before cancer-directed therapy begins.

Bedside takeaway

Surface reproductive goals before chemotherapy and help complete timely fertility-preservation referrals through the approved oncology pathway.

Nursing implications

Ask about reproductive goals before treatment when appropriate, document concerns, and route timely referrals through the oncology team's fertility-preservation pathway. Present recovery estimates as pooled probabilities rather than predictions for an individual patient.

Limitations & cautions

The studies varied in populations, treatments, and definitions of ovarian recovery. Confidence intervals were wide, especially at 60 months, and the abstract does not establish which fertility-preservation strategy is best for an individual patient.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Breast Cancer Research and Treatment (PubMed). Recovery of ovarian function after chemotherapy in premenopausal women with breast cancer: a systematic review and meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of Neurology (PubMed)Sep 20, 2026Systematic Review

A systematic review characterized cancer-associated coagulopathy stroke as an underrecognized ischemic stroke mechanism linked to advanced cancer, early recurrence, and poor outcomes.

Emergency OncologyAI summaryReview source

Systematic ReviewResearchMedication SafetyWorkflowAI summary · original source linked below

The qualitative review included 82 studies. Cancer-associated coagulopathy stroke occurred predominantly within six months of cancer diagnosis, most often with advanced or metastatic adenocarcinoma; D-dimer was the biomarker most consistently associated with recurrence and mortality, and reported 30-day mortality ranged from 25% to 50%.

Key takeaways

Lung and pancreatic adenocarcinomas were the histologic subtypes most frequently associated with cancer-related coagulopathy stroke.
Multiple infarcts across more than two vascular territories were a characteristic imaging pattern described in the review.
Low-molecular-weight heparin and direct oral anticoagulants were commonly used for secondary prevention, but the review did not establish one optimal antithrombotic strategy.

Why this matters on shift

Neuro and oncology nurses may be first to recognize a new focal deficit or recurrent neurologic change in a patient with active cancer. The review highlights a high-risk stroke mechanism that requires rapid assessment while leaving treatment selection to individualized multidisciplinary evaluation.

Bedside takeaway

Escalate new neurologic deficits immediately and communicate the patient's cancer and antithrombotic context to the stroke team.

Nursing implications

Treat any new focal neurologic deficit as an emergency, document onset and progression precisely, and promptly communicate active or metastatic cancer, recent cancer diagnosis, coagulation results, and current antithrombotic therapy to the stroke team. Follow facility stroke and anticoagulation protocols and provider orders.

Limitations & cautions

The review synthesized heterogeneous studies qualitatively and did not report a pooled treatment comparison. Biomarkers other than D-dimer had limited specificity, and the abstract does not support choosing one anticoagulant or screening strategy.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of Neurology (PubMed). Stroke secondary to cancer-associated coagulopathy: a systematic review.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Frontiers in Public Health (PubMed)Sep 3, 2026Research Article

A pilot cluster-randomized trial found that a staff-mediated doll-therapy care package was feasible and produced a preliminary reduction in behavioral and psychological symptoms among Chinese nursing-home residents with dementia.

Geriatrics PsychAI summaryReview source

Research ArticleResearchPatient EducationWorkflowAI summary · original source linked below

Six nursing homes enrolled 142 residents, and 130 completed 12-week follow-up. The intervention group had greater improvement on the 12-item Neuropsychiatric Inventory at 6 and 12 weeks, but psychotropic medication doses did not differ and functional improvement was not sustained.

Key takeaways

Most intervention participants attended at least six of eight sessions, and mean delivery fidelity was 94.1%.
Six possibly or probably related events were mild or moderate, with no related serious event.
Staff and family interviews emphasized non-deceptive introductions, respect for refusal, training, and recognition that some residents had no response or an adverse response.

Why this matters on shift

Residential-care nurses balance nonpharmacologic symptom support with dignity, consent, safety, and individual response. The pilot offers a carefully bounded person-centered option while showing that it did not reduce psychotropic doses and is not appropriate for every resident.

Bedside takeaway

If doll therapy is in the care plan, use a non-deceptive approach, respect refusal, and monitor each resident's response.

Nursing implications

Use doll therapy only within an approved individualized care plan, introduce it without deception, observe the resident's verbal and nonverbal response, and stop when the resident refuses or becomes distressed. Continue assessment for unmet physical, environmental, and psychosocial needs under facility protocol.

Limitations & cautions

This exploratory study involved only six nursing homes, lacked an attention-control condition, and was not designed as definitive effectiveness evidence. Medication effects were imprecise, functional improvement was not sustained, and findings may not generalize beyond the studied care setting.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Frontiers in Public Health (PubMed). Staff-mediated doll therapy in Chinese residential dementia care: an exploratory pilot and feasibility mixed-methods cluster randomized clinical trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Ovarian function recovery after breast cancer chemotherapy remained limited

Cancer-associated coagulopathy stroke carried high early recurrence and mortality risk

Staff-mediated doll therapy showed a preliminary behavioral benefit in dementia care